NeuroOne Medical Technologies
NMTC
7 hedge funds and large institutions have $989K invested in NeuroOne Medical Technologies in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
133% more funds holding
Funds holding: 3 → 7 (+4)
0.22% less ownership
Funds ownership: 0.57% → 0.35% (-0.22%)
64% less capital invested
Capital invested by funds: $2.73M → $989K (-$1.74M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$508K |
| 2 |
IC
Intersect Capital
San Ramon,
California
|
+$239K |
| 3 |
HF
HRT Financial
New York
|
+$187K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$23.5K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$2.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAAM
Baker Avenue Asset Management
San Francisco,
California
|
-$1.19M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $419K | +$508K | +17,692 | New |
|
|
IC
2
Intersect Capital
San Ramon,
California
| $198K | +$239K | +8,333 | New |
|
|
PAM
3
Premier Asset Management
Chicago,
Illinois
| $197K | – | – | – |
|
|
HF
4
HRT Financial
New York
| $154K | +$187K | +6,529 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $20K | +$23.5K | +818 | New |
|
|
CG
6
Cutler Group
San Francisco,
California
| $1K | +$2.38K | +83 | New |
|
|
BAAM
7
Baker Avenue Asset Management
San Francisco,
California
| – | -$1.19M | -29,895 | Closed |
|
8
Wells Fargo
San Francisco,
California
| – | +$258 | +9 | New |
|
NMTC Hedge Fund Activity: Q3 2021 in Review
7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2021, worth a combined $989K — down 64% from $2.73M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NMTC positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $508K. The largest seller was Baker Avenue Asset Management, exiting entirely with an estimated $1.19M sold.
- 7 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2021, up from 3 in Q2 2021.
- Funds reported $989K of NeuroOne Medical Technologies stock for Q3 2021, down 64% quarter-over-quarter.
- 6 funds opened new NeuroOne Medical Technologies positions in Q3 2021 and 1 closed out, a net change of +5 holders.
- The largest NeuroOne Medical Technologies buyer in Q3 2021 was Millennium Management, an estimated $508K added.
- The largest NeuroOne Medical Technologies seller in Q3 2021 was Baker Avenue Asset Management, an estimated $1.19M sold.
Based on aggregated 13F filings for Q3 2021.